Diabetes Drugs
Product Name
Tagrisso is a prescription medication used to treat specific types of non-small cell lung cancer (NSCLC) that carry mutations in the EGFR gene.
Please note: a valid prescription is required for all prescription medication.
Tagrisso is a third-generation tyrosine kinase inhibitor designed to target epidermal growth factor receptor (EGFR) mutations, helping control the growth of cancer cells in NSCLC. This advanced therapy offers proven benefits, including longer progression-free survival and improved overall outcomes compared to earlier EGFR inhibitors.
Tagrisso is available in dose options designed to match your treatment plan and your doctor’s prescription:
Tagrisso 40 mg, 30 tablets.
Tagrisso 80 mg, 30 tablets.
No reviews yet.
No shipping information available.
No rewards information available.
No doctor visit information available.
Hemangiol is a prescription medication formulated as an oral solution of propranolol 3.75 mg/mL, used for the treatment of proliferating infantile hemangioma...
Advair Diskus is a prescription inhaler used to help control asthma and manage symptoms of Chronic Obstructive Pulmonary Disease (COPD). It combines two medi...
Betahistine is a prescription medication used to reduce the frequency and intensity of vertigo episodes, especially in patients diagnosed with Ménière’s dise...
Donepezil is a prescription medication used to treat symptoms of Alzheimer’s disease by boosting brain chemicals involved in memory, thinking, and reasoning,...
Diabetes Drugs
Product Name
Your cart is empty